bpc-157 fda category 2 compounding bpc 157 news bulk drug substances list HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list — reversing the 2023 BPC-157 Canada Research Guide 2026:

Inositol regulates insulin sensitivity and promotes fat breakdown at the cellular level

Tirzepatide controls blood sugar by stimulating insulin release, lowering glucagon levels and regulating appetite and energy metabolism for weight management

One of the arguments for this is that NAD is a large molecule that's not as easily absorbed in the body, so taking smaller compounds and allowing the body to convert them once they're absorbed might actually raise be more efficient in terms of how much NAD+ you get but there's still no definitive answer to which method works best, so what's the difference in dosages if you're taking an NAD precursor

Drug Interactions: Inform your healthcare provider about all medications and supplements you are taking